MetaCurUm

Image -

MetaCurUm

Maréne Landström and Maarten de Château from MetaCurUm Biotech AB.
Metacurum
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By:
Metacurum
File format:
.png
Size:
1920 x 1080, 950 KB
Download

Topics

Contacts

Related content

  • Maréne Landström, founder of MetaCurUm Biotech AB, and Maarten de Château, CEO.

    MetaCurUm aims to raise SEK 100 Million - following founder's prestigious Award

    MetaCurUm Biotech AB plans to raise 100 million SEK following founder Maréne Landström being named Sweden's Cancer Researcher of the Year. Their groundbreaking cancer treatment, still in the preclinical phase, aims to halt the TGFβ pathway cancer cells utilize. The Umeå based company is collaborating with international researchers and exploring biomarkers for patient stratification.

  • Metacurum, based on Professor Maréne Landströms research and with Maarten de Château as CEO, is collaborating with the Institute for Cancer Research in London and Professor Johan de Bono.

    MetaCurUm Secures SEK 1 Million Grant for Cancer Treatment

    MetaCurUm AB has received a SEK 1 million grant from the Swedish Innovation Agency Vinnova to advance its therapeutic antibody for prostate cancer toward clinical trials. The Vinnova funds will be used further to validate MetaCurUm's mechanism of action and product. MetaCurUm is collaborating with the Institute of Cancer Research in London and Professor Johan de Bono.

Umeå Biotech Incubator Enter your email address to follow Umeå Biotech Incubator

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Umeå Biotech Incubator Check your inbox

Email sent to __email__. Click the link there to follow Umeå Biotech Incubator.

Okay